Barone Mark Thomaz Ugliara, Ngongo Belinda, Harnik Simone Bega, Oliveira Lucas Xavier de, Végh Dániel, de Luca Patrícia Vieira, Pedrosa Hermelinda Cordeiro, Giraudo Franco, Cardona-Hernandez Roque, Chaudhury Nayanjeet, Menna-Barreto Luiz
International Diabetes Federation (IDF), 166 Chaussee de La Hulpe B-1170 Brussels, Belgium; ADJ Diabetes Brasil (ADJ), Rua Padre Antônio Tomás, 213, Zip Code 05003-010, Água Branca, São Paulo, SP, Brazil; Fórum Intersetorial para Combate às DCNTs no Brasil (ForumDCNTs), Rua Padre Antônio Tomás, 213, Zip Code 05003-010, Água Branca, São Paulo, SP, Brazil; Sociedade Brasileira de Diabetes (SBD), Rua Afonso Braz 579, Salas 72/74, Vila Nova Conceição, Zip Code 04511-011, São Paulo, SP, Brazil.
Pan African Women in Health (PAWH), P.O. Box 95535, Grant Park, 2051, South Africa.
Diabetes Res Clin Pract. 2021 Jan;171:108587. doi: 10.1016/j.diabres.2020.108587. Epub 2020 Dec 9.
COVID-19 has gravely threatened high-risk populations, such as people with diabetes and other noncommunicable diseases, leading to disproportionate hospitalizations and deaths worldwide. It is well documented from previous outbreaks that diabetes increases the risk for poor outcomes due to SARS infection. In the present review, we bring evidence that the country and global level health crisis caused by COVID-19 could have been avoided or extremely minimized if measures to protect high-risk populations were implemented timely. In addition to general lockdowns, testing, tracing, isolation and hygiene measures, other specific interventions for diabetes and comorbidities management were shown crucial to allow the continuation of care services during the pandemic. These interventions included: teleconsultation, digital remote education andmonitoring, e-prescriptions, medicine delivery options, mobile clinics, and home point-of-care tests. In conclusion, we recommend prompt actions to protect the most vulnerable groups, valuing knowledge and experiences from previous outbreaks and lessons learned during the COVID-19 pandemic, in order to shield communities, health systems and the global economy.
新冠病毒病(COVID-19)已严重威胁到糖尿病患者和其他非传染性疾病患者等高危人群,导致全球范围内不成比例的住院率和死亡率。以往疫情充分证明,糖尿病会增加因感染严重急性呼吸综合征(SARS)而出现不良后果的风险。在本综述中,我们提供证据表明,如果及时实施保护高危人群的措施,由COVID-19引发的国家和全球层面的健康危机本可避免或极大程度地减轻。除了全面封锁、检测、追踪、隔离和卫生措施外,其他针对糖尿病及合并症管理的特定干预措施对于在疫情期间维持护理服务至关重要。这些干预措施包括:远程会诊、数字远程教育与监测、电子处方、药品配送选项、流动诊所和家庭即时检测。总之,我们建议迅速采取行动保护最脆弱群体,重视以往疫情的知识和经验以及在COVID-19大流行期间吸取的教训,以保护社区、卫生系统和全球经济。